The Switzerland stock market concluded Monday's session on a strong note, aligning with the upward trend in European markets. This positive movement followed the announcement from the Trump administration about delaying the implementation of new trade tariffs.
The Swiss Market Index (SMI) experienced an initial dip at the opening, showed signs of weakening around midday, but subsequently rebounded to conclude the trading day positively.
The SMI rose by 46.95 points, or 0.39%, to settle at 12,037.22, after fluctuating between a low of 11,983.25 and a high of 12,055.00 during the day.
Key performers included Kuehne + Nagel, which surged by nearly 2.5%, UBS Group with a 2% gain, and Lonza Group, which added 1.6%. Sika, Straumann Holding, Adecco, and Alcon also saw increases, ranging from 1% to 1.2%.
Other companies such as Givaudan, Swatch Group, Sandoz Group, Julius Baer, Lindt & Spruengli, Partners Group, Roche Holding, ABB, Sonova, and VAT Group recorded modest upticks.
Belimo Holding advanced by approximately 2.3% following a year-over-year rise in net sales to 943.9 million Swiss francs, up from 858.8 million francs.
Conversely, Zurich Insurance Group fell by 1.67%, Schindler Ps dropped 0.71%, and Swiss Life Holding decreased by 0.5%.
According to the Federal Statistical Office, Switzerland's producer and import prices continued to decline in December, albeit at a slower rate over the last fourteen months.
In December, producer and import prices fell by 0.9% compared to the previous year, improving from a 1.5% decrease in November. This marks a continued decline since May 2023; however, the recent drop was the mildest since October of the prior year, when prices had increased by 0.9%.
Annually, the producer price index slid by 0.1% in December, while import prices decreased by 2.6%.
On a monthly comparison, producer and import prices remained unchanged in December, contrasting with a 0.6% decline in November. The average annual decrease rate in producer and import prices was 1.7% in 2024, largely due to reduced pricing for pharmaceutical products.
